Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Feng Zheng, Biao Zhang, Yanan Sun, Mingfeng Qiu & Jing Su. (2015) Evaluation of WO2011045166A1, Fkbp52–tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction. Expert Opinion on Therapeutic Patents 25:7, pages 831-835.
Read now
Read now
Articles from other publishers (20)
Yi Zhang, Haifeng Xu, Sainan Pi, Huiqian Tan, Bihui Huang & Youpeng Chen. (2023) The prognostic and immunological role of FKBP1A in an integrated muti-omics cancers analysis, especially lung cancer. Journal of Cancer Research and Clinical Oncology 149:18, pages 16589-16608.
Crossref
Crossref
Yue Shi, Jinyao Zhang, Zheng Ma, Yongyong Zhang, Andreas Bechthold & Xiaoping Yu. (2023)
Double‐reporter‐guided targeted activation of the oxytetracycline silent gene cluster in
Streptomyces rimosus
M527
. Biotechnology and Bioengineering 120:5, pages 1411-1422.
Crossref
Crossref
Tianbai Zhong, Xiuyun Sun, Li Yu, Yongbo Liu, Xin Lin, Yu Rao & Wei Wu. (2022) PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Donghuan Sun, Jing Zhang, Guoqiang Dong, Shipeng He & Chunquan Sheng. (2022) Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation. Journal of Medicinal Chemistry 65:21, pages 14276-14288.
Crossref
Crossref
Gabriella Caminati & Piero Procacci. (2020) Mounting evidence of FKBP12 implication in neurodegeneration. Neural Regeneration Research 15:12, pages 2195.
Crossref
Crossref
Dorota Kostrz, Hannah K. Wayment-Steele, Jing L. Wang, Maryne Follenfant, Vijay S. Pande, Terence R. Strick & Charlie Gosse. (2019) A modular DNA scaffold to study protein–protein interactions at single-molecule resolution. Nature Nanotechnology 14:10, pages 988-993.
Crossref
Crossref
Zahra Nadia Sharifi, Hamid Zaferani Arani, Maedeh Olya, Hesam Adin Atashi & Shabnam Movassaghi. (2019) Effect of Different Doses and Times of FK506 on Different Areas of the Hippocampus in the Rat Model of Transient Global Cerebral Ischemia-Reperfusion. Neurology Research International 2019, pages 1-7.
Crossref
Crossref
Carmelo Luca Smeralda, Gian Luigi Gigli, Alberto Vogrig, Alessandro Marini & Mariarosaria Valente. (2019) Tacrolimus-induced severe headache associated with diffuse leukoencephalopathy: Evidence for an immune-mediated pathogenesis. Journal of Neuroimmunology 330, pages 55-58.
Crossref
Crossref
Mario D. Galigniana. 2019. Heat Shock Protein 90 in Human Diseases and Disorders. Heat Shock Protein 90 in Human Diseases and Disorders
19
45
.
Gleb Solomentsev, Carl Diehl & Mikael Akke. (2018) Conformational Entropy of FK506 Binding to FKBP12 Determined by Nuclear Magnetic Resonance Relaxation and Molecular Dynamics Simulations. Biochemistry 57:9, pages 1451-1461.
Crossref
Crossref
Yao Zong Ng, Pedro A. Baldera-Aguayo & Virginia W. Cornish. (2017) Fluorescence Polarization Assay for Small Molecule Screening of FK506 Biosynthesized in 96-Well Microtiter Plates. Biochemistry 56:40, pages 5260-5268.
Crossref
Crossref
Marine Bacchi, Magali Jullian, Serena Sirigu, Benjamin Fould, Tiphaine Huet, Lisa Bruyand, Mathias Antoine, Laurent Vuillard, Luisa Ronga, Leonard M. G. Chavas, Olivier Nosjean, Gilles Ferry, Karine Puget & Jean A. Boutin. (2016) Total chemical synthesis, refolding, and crystallographic structure of fully active immunophilin calstabin 2 (FKBP12.6). Protein Science 25:12, pages 2225-2242.
Crossref
Crossref
Baolin Zhao, Minghui Lv, Zengxiu Feng, Thomas Campbell, Emmanuel Liscum & Jia Li. (2016) TWISTED DWARF 1 Associates with BRASSINOSTEROID-INSENSITIVE 1 to Regulate Early Events of the Brassinosteroid Signaling Pathway. Molecular Plant 9:4, pages 582-592.
Crossref
Crossref
A.A. Stepanenko, S.V. Andreieva, K.V. Korets, D.O. Mykytenko, V.P. Baklaushev, V.P. Chekhonin & V.V. Dmitrenko. (2016) mTOR inhibitor temsirolimus and MEK1/2 inhibitor U0126 promote chromosomal instability and cell type-dependent phenotype changes of glioblastoma cells. Gene 579:1, pages 58-68.
Crossref
Crossref
Gisela I. Mazaira, María F. Camisay, Sonia De Leo, Alejandra G. Erlejman & Mario D. Galigniana. (2016) Biological relevance of Hsp90-binding immunophilins in cancer development and treatment. International Journal of Cancer 138:4, pages 797-808.
Crossref
Crossref
A. Sean Alemi, Kristina W. Rosbe, Dylan K. Chan & Anna K. Meyer. (2015) Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations. International Journal of Pediatric Otorhinolaryngology 79:12, pages 2466-2469.
Crossref
Crossref
A.A. Stepanenko & V.V. Dmitrenko. (2015) Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability. Gene 574:2, pages 193-203.
Crossref
Crossref
Ana Gil-Bona, Lucía Monteoliva & Concha Gil. (2015)
Global Proteomic Profiling of the Secretome of
Candida albicans ecm33
Cell Wall Mutant Reveals the Involvement of Ecm33 in Sap2 Secretion
. Journal of Proteome Research 14:10, pages 4270-4281.
Crossref
Crossref
Gianluca Lorenzo Perrucci, Aoife Gowran, Marco Zanobini, Maurizio Colognesi Capogrossi, Giulio Pompilio & Patrizia Nigro. (2015) Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases. Cardiovascular Research 106:3, pages 353-364.
Crossref
Crossref
Muhamad A Rostam, Terrence J Piva, Hossein B Rezaei, Danielle Kamato, Peter J Little, Wenhua Zheng & Narin Osman. (2015) Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease. Clinical and Experimental Pharmacology and Physiology 42:2, pages 117-124.
Crossref
Crossref